Study Participation Information
The BreenLab at NC State University sends our sincre appreciation to the many people who have submitted valuable cancer specimens from their dogs to be included in our research progam. Without these precious samples we would not have been able to perform the research that is now leading to new discoveries to enhance the lives of all dogs, and perhaps people, with several types of cancer.
At this time we are suspending recruitment of new cases so that we can allocate all our time and resources to analysing the cases already submitted.
We are delighted to report that these studies have already led to the development of the following genetic tests
AVAILABLE NOW under the CAncer DETection (CADET) brand of Sentinel Biomedical.
Detection of canine bladder/prostate cancer
The CADET BRAF Mutation Detection Assay provides a test for early detection, diagnosis and monitoring of canine bladder and prostate cancer – also known as transitional cell carcinoma (TCC)/urothelial carcinoma (UC).
The CADET BRAF Mutation Detection Assay is available in two forms: i) as a diagnositic and monitoring assay through Sentinel Biomedical for dogs that have symptoms of a bladder/prostate cancer, and ii) as a screening assay through the American Kennel Club, for early detection of TCC/UC in pre-symptomatic dogs of high risk breeds. Both tests are based on the submission of a non-invasive, free catch urine specimen.
Detection of canine histiocytic malignacies
The CADET HM Assay is a genetic test that aids distinction between hisiocytic malignancies and other round cell neoplasms (eg lymphoma, hemangiosarcoma) that may share similar symptoms and histologic appearance. Sample submission is a cytological smear of aspirated cells or a formalin-fixed paraffin-embedded biopsy specimen.
Detection of a BCR-ABL translocation in canine leukemia
The CADET BCR-ABL Assay is a genetic test that identifies the presence of a BCR-ABL fusion in canine leukemias, used by veterinarians to determine the likely efficacy of tyrosine kinase inhibitor based therapy. Sample submission is an EDTA/lila top blood tube.
For canine lymphoma : a genetic test to predict how long a dog with lymphoma will remain in remission when treated with chemotherapy. Sample submission is a fine needle aspirate, cytologiy prepapration, or formalin fixed paraffin embeded biopsy specimen of an affeted lymph node prior to any chemotherpay treatment.
For canine melanoma : a genetic test to identify agressive canine mucosal melanoma. Sample submission is a fine needle aspirate, cytology preparation, or formalin fixed paraffin embeded biopsy specimen of an oral mass.
Full mailing address and contact details for further information
North Carolina State University
College of Veterinary Medicine
CVM Research Building, Room 330
1060 William Moore Drive
NC 27607, USA
Tel: 919-513-1466 Fax: 919-513-7301